Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Samsung Biologics receives the Terra Carta Seal in recognition of the company's commitment to creating a sustainable future 2023-01-11 08:01
Dizal Announces China CDE Acceptance of New Drug Application for Sunvozertinib for Platinum-Pretreated NSCLC Patients with EGFR Exon20ins Mutations 2023-01-10 17:03
SK Biopharmaceuticals to Present Future Plan for Global Investors, Partners at 'SK Bio Night' 2023-01-10 07:00
SK Inc. hosts "SK Bio Night" in San Francisco to expand global partnerships 2023-01-10 07:00
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in the United States for the Treatment of Individuals with Multiple System Atrophy 2023-01-09 23:25
SK bioscience's Zoster Vaccine Receives Biologics License Application Approval in Malaysia 2023-01-09 21:00
Immorna Receives IND Clearance to Conduct a Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Shingles Vaccine 2023-01-09 20:00
Jacobio Completes First Patient Dosage of Aurora A Inhibitor JAB-2485 in U.S 2023-01-08 14:17
Fosun Pharma and Henlius Entered into an Exclusive License Agreement for Serplulimab in the US 2023-01-07 17:29
Ocedurenone (KBP-5074) Featured at ASN Kidney Week: Ocedurenone is a Potential New Treatment Option for Patients with Uncontrolled or Resistant Hypertension and Advanced CKD 2023-01-06 21:00
Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation) 2023-01-06 20:25
Double-blind period completes! Primary endpoint analysis of phase 3 clinical trial to be conducted for China's first hormone replacement treatment targeting hypoparathyroidism 2023-01-06 18:00
Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo 2023-01-05 09:00
Innovent to Present at 41st Annual J.P. Morgan Healthcare Conference 2023-01-05 00:00
OnCusp Therapeutics Announces Appointment of Robert Forrester and Chau Khuong to Board of Directors 2023-01-04 21:00
ProfoundBio Announces Initiation of First-in-Human Trial for PRO1184, a Folate Receptor Alpha-Directed ADC with a Topoisomerase 1 Inhibitor Payload, and Receives FDA "Study May Proceed" Letter for PRO1160, a CD70-Directed ADC 2023-01-03 20:00
Antengene to Present at the 41st Annual J.P. Morgan Healthcare Conference 2023-01-03 14:10
Qilu Pharmaceutical Announces Progress of Clinical Study of QL1706, an Innovative Bifunctional Antibody 2022-12-29 14:32
Hyphens Pharma licenses Winlevi® for all 10 ASEAN countries from Cosmo Pharmaceuticals 2022-12-23 17:00
FDA agrees to Actinogen six-month Phase 2b Alzheimer's Disease trial 2022-12-22 20:30
1 60 61 62 63 64 165